These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12362216)

  • 41. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
    Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
    Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adverse events of HP eradication: long-term negative consequences of HP eradication.
    Koster ED
    Acta Gastroenterol Belg; 1998; 61(3):350-1. PubMed ID: 9795471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Association between Helicobacter pylori and gastro-esophageal reflux disease].
    Rhee PL
    Korean J Gastroenterol; 2003 Sep; 42(3):179-82. PubMed ID: 14532738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S; Murakami M; Saita H; Tsuji S
    J Gastroenterol; 1996 Nov; 31 Suppl 9():41-3. PubMed ID: 8959517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Barrett's esophagus and Helicobacter pylori].
    Sakata H; Fujimoto K
    Nihon Rinsho; 2005 Aug; 63(8):1383-6. PubMed ID: 16101226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus.
    Loffeld RJ; Werdmuller BF; Kuster JG; Pérez-Pérez GI; Blaser MJ; Kuipers EJ
    Digestion; 2000; 62(2-3):95-9. PubMed ID: 11025356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.
    Sugimoto M; Uotani T; Ichikawa H; Andoh A; Furuta T
    Digestion; 2016; 93(1):24-31. PubMed ID: 26789391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study.
    Xue Y; Zhou LY; Lin SR; Hou XH; Li ZS; Chen MH; Yan XE; Meng LM; Zhang J; Lu JJ
    Chin Med J (Engl); 2015 Apr; 128(8):995-9. PubMed ID: 25881589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.
    Clark GW
    World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East.
    Rajendra S; Ackroyd R; Robertson IK; Ho JJ; Karim N; Kutty KM
    Helicobacter; 2007 Apr; 12(2):177-83. PubMed ID: 17309756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
    Castell DO; Katz PO
    Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
    [No Abstract]   [Full Text] [Related]  

  • 54. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
    Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
    Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastroesophageal reflux disease and the relationship with Helicobacter pylori.
    Mungan Z; Pınarbaşı Şimşek B
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S61-S67. PubMed ID: 29199171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The possible role of Helicobacter pylori in GERD.
    Falk GW
    Semin Gastrointest Dis; 2001 Jul; 12(3):186-95. PubMed ID: 11478751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helicobacter pylori and gastroesophageal reflux disease.
    Kandulski A; Malfertheiner P
    Curr Opin Gastroenterol; 2014 Jul; 30(4):402-7. PubMed ID: 24848647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.